跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17 条关于
“RenovoCath”
全部
17
临床试验
3
药物
0
机构
0
资讯
14
去年
RenovoRx Boosts RenovoCath Production Amid Rising Demand for Targeted Oncology Therapies
去年
RenovoRx Launches Multi-Center PanTheR Registry Study to Evaluate Real-World Safety of RenovoCath Device
去年
RenovoRx Secures New U.S. Patent for TAMP Therapy Platform, Strengthening IP Portfolio for Targeted Cancer Treatment
去年
RenovoRx Reports Strong Q2 2025 Commercial Growth and Positive Phase III Trial Continuation
去年
RenovoRx Announces Investor Fireside Chat and Provides Update on TIGeR-PaC Trial
去年
Johns Hopkins Medicine Joins RenovoRx's Phase III Pancreatic Cancer Trial as New Enrollment Site
去年
RenovoRx's TAMP Platform Shows Promise in Targeted Cancer Therapy
去年
Northwell Health Cancer Institute Joins RenovoRx's Phase III TIGeR-PaC Trial for Pancreatic Cancer
去年
Northwell Health Joins RenovoRx's Phase III Trial for Pancreatic Cancer
去年
RenovoRx Secures $12.1M Through Public Offering to Advance Pancreatic Cancer Trial
第 1 页,共 2 页
上一页
下一页